Yamamoto, Yasuhiko

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal

Advanced Glycation End Products researchRetinal Diseases and Treatments

Cited by 716

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 475

Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS

Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., et al. (2011) · The Journal of Immunology

Advanced Glycation End Products researchImmune Response and Inflammation

Cited by 207

Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice

Yamamoto, Y., Liang, M., Munesue, S., Deguchi, K., Harashima, A., Furuhara, K., Yuhi, T., Zhong, J., Akther, S., Goto, H., et al. (2019) · Communications Biology

Neuroendocrine regulation and behaviorBarrier Structure and Function Studies

Cited by 171

RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication

Yamamoto, Y., & Yamamoto, H. (2013) · Frontiers in Endocrinology

Advanced Glycation End Products researchAdipokines, Inflammation, and Metabolic Diseases

Cited by 99

RAGE mediates vascular injury and inflammation after global cerebral ischemia

Kamide, T., Kitao, Y., Takeichi, T., Okada, A., Mohri, H., Schmidt, A. M., Kawano, T., Munesue, S., Yamamoto, Y., Yamamoto, H., et al. (2012) · Neurochemistry International

Advanced Glycation End Products researchNeurological Disease Mechanisms and Treatments

Cited by 60

CD38, CD157, and RAGE as Molecular Determinants for Social Behavior

Higashida, H., Hashii, M., Tanaka, Y., Matsukawa, S., Higuchi, Y., Gabata, R., Tsubomoto, M., Seishima, N., Teramachi, M., Kamijima, T., et al. (2019) · Cells

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 58

CD38 positively regulates postnatal development of astrocytes cell-autonomously and oligodendrocytes non-cell-autonomously: HATTORI et al.

Hattori, T., Kaji, M., Ishii, H., Jureepon, R., Takarada-Iemata, M., Minh Ta, H., Manh Le, T., Konno, A., Hirai, H., Shiraishi, Y., et al. (2017) · Glia

Neurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 53

Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells

Yamamoto, Y., Yonekura, H., Watanabe, T., Sakurai, S., Li, H., Harashima, A., Myint, K. M., Osawa, M., Takeuchi, A., Takeuchi, M., et al. (2007) · Diabetes Research and Clinical Practice

Advanced Glycation End Products researchRetinal Diseases and Treatments

Cited by 44

Deletion of RAGE Causes Hyperactivity and Increased Sensitivity to Auditory Stimuli in Mice

Sakatani, S., Yamada, K., Homma, C., Munesue, S., Yamamoto, Y., Yamamoto, H., & Hirase, H. (2009) · PLoS ONE

Advanced Glycation End Products researchNeuroscience and Neuropharmacology Research

Cited by 42

Cyclic ADP-Ribose and Heat Regulate Oxytocin Release via CD38 and TRPM2 in the Hypothalamus during Social or Psychological Stress in Mice

Zhong, J., Amina, S., Liang, M., Akther, S., Yuhi, T., Nishimura, T., Tsuji, C., Tsuji, T., Liu, H.-X., Hashii, M., et al. (2016) · Frontiers in Neuroscience

Neuroendocrine regulation and behaviorCalcium signaling and nucleotide metabolism

Cited by 42

cAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-products

Motoyoshi, S., Yamamoto, Y., Munesue, S., Igawa, H., Harashima, A., Saito, H., Han, D., Watanabe, T., Sato, H., & Yamamoto, H. (2014) · Biochemical Journal

Advanced Glycation End Products researchImmune Response and Inflammation

Cited by 20

Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice

Liu, L., Killoy, K. M., Vargas, M. R., Yamamoto, Y., & Pehar, M. (2020) · Pharmacology Research & Perspectives

Amyotrophic Lateral Sclerosis ResearchAdvanced Glycation End Products research

Cited by 17

Deletion of CD38 and supplementation of NAD+ attenuate axon degeneration in a mouse facial nerve axotomy model

Takaso, Y., Noda, M., Hattori, T., Roboon, J., Hatano, M., Sugimoto, H., Brenner, C., Yamamoto, Y., Okamoto, H., Higashida, H., et al. (2020) · Scientific Reports

Nerve injury and regenerationFacial Nerve Paralysis Treatment and Research

Cited by 17